Vidyo nabs $15 mln

By Iris Dorbian — 2 months ago

Hackensack, New Jersey-based visual communications company Vidyo Inc has raised $15 million in funding. The investors included Kaiser Permanente Ventures, Menlo Ventures, Rho Ventures, Sevin Rosen Funds and QuestMark Partners. 

Continue

Norwest leads funding round for Health Catalyst

By Alastair Goldfisher — 11 months ago

Health Catalyst, a provider of healthcare data warehousing services, announced it has raised $70 million in new funding, bringing the total amount raised by the Salt Lake City-based company to $170 million. Existing investor Norwest Venture Partners led the latest round, which included other previous investors Sequoia Capital, Kaiser Permanente Ventures, Sorenson Capital, CHV Capital and Partners HealthCare. New investors Sands Capital Ventures, Tenaya Capital, Epic Ventures and Leavitt Equity Partners also participated.

Continue

Kit Check rakes in $12 mln Series B

By Iris Dorbian — 1 year ago

Washington, D.C.-based Kit Check, a provider of hospital pharmacy kit processing and medication tracking software, has secured $12 million in Series B funding. Kaiser Permanente Ventures led the round with participation from other investors that included Rex Health Ventures. In addition to the funding, Dave Schulte, vice president and senior managing director of Kaiser Permanente Ventures, has been appointed to Kit Check’s board of directors.

Continue

Ascension Ventures, Heritage, Kaiser invest in Ingenious Med

By Luisa Beltran — 1 year ago

Ascension Ventures, Heritage Group and Kaiser Permanente Ventures are investing in Ingenious Med, which is backed by North Bridge Growth Equity. Atlanta-based Ingenious Med provided a cloud-based patient encounter platform that aims to automate physician and care team workflow at the point of care. North Bridge acquired a majority stake in the company in 2014 and remains lead investor.

Continue

Rock Health snags seed funding

By Iris Dorbian — 1 year ago

Rock Health, a San Francisco-based digital health accelerator, has received an undisclosed amount of seed funding, the company announced in a blog post on its site. Bessemer Venture Partners and Kaiser Permanente Ventures led the round with participation from KPCB, Montreux Equity Partners and Great Oaks Ventures. To read more details about the funding, visit here.

Continue

MetricStream secures funds led by Sageview

By Angela Sormani — 1 year ago

MetricStream has raised $60 million in a financing round led by Sageview Capital. Existing investors Goldman Sachs and Kaiser Permanente Ventures also participated. MetricStream is a provider of enterprise and cloud applications for GRC.

Continue

MetricStream bags $60 mln

By Iris Dorbian — 1 year ago

MetricStream, a Palo Alto, Calif.-based provider of governance, risk and compliance solutions, has received $60 million in funding. Sageview Capital led the round with participation from previous backers Goldman Sachs and Kaiser Permanente Ventures. In addition to the funding, Ned Gilhuly, Sageview Capital’s co-founder and managing partner of Sageview Capital, has been added to MetricStream’s board of directors.

Continue

VC-backed Agile Therapeutics rolls out IPO

By Iris Dorbian — 2 years ago

Agile Therapeutics has launched its IPO after pricing its over 9.16 million shares at $6 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “AGRX.” RBC Capital Markets and William Blair & Company are the lead underwriters. Based in Princeton, NJ, Agile Therapeutics develops prescription contraceptives. Its backers include Aisling Capital, Care Capital, Investor Growth Capital, ProQuest Investments, Kaiser Permanente Ventures and Novitas Capital.

Continue

Andreessen Horowitz leads Series B round for Omada Health

By Iris Dorbian — 2 years ago

Digital therapeutics firm Omada Health said Wednesday that it has raised $23 million in Series B financing. Andreessen Horowitz led the round with participation from Kaiser Permanente Ventures and previous backers that include U.S. Venture Partners and The Vertical Group. Also, Balaji S. Srinivasan, a general partner at Andreessen Horowitz, has been added to Omada Health’s board of directors.

Continue

VC-backed Agile Therapeutics files for IPO

By Iris Dorbian — 2 years ago

Agile Therapeutics has filed for an IPO. The number of shares that will be offered as well as the pricing terms of the stock have yet to be set. RBC Capital Markets and William Blair & Company will serve as the lead underwriters. Based in Princeton, NJ, Agile Therapeutics is a women’s health specialty pharmaceutical company focused on developing prescription contraceptives. Its backers include Aisling Capital, Care Capital, Investor Growth Capital, ProQuest Investments, Kaiser Permanente Ventures and Novitas Capital.

Continue

VC-backed TriVascular files for IPO

By Iris Dorbian — 2 years ago

TriVascular Technologies has filed for an IPO. The number of shares that will be offered as well as its pricing terms have yet to be set. The stock will trade on the NASDAQ under the ticker symbol “TRIV.” J.P. Morgan Securities and Credit Suisse Securities are the lead underwriters. Based in Santa Rosa, Calif., TriVascular Technologies is a provider of endovascular aortic repair solutions. Its backers include NEA, Delphi Ventures, MPM Capital, Kearny Venture Partners, Kaiser Permanente Ventures, Rock Springs Capital and Permal Asset Management.

Continue

Kaiser Permanente Ventures and CHV Capital Back Health Catalyst

By Connie Loizos — 3 years ago

Health Catalyst, a Salt Lake City-based data warehousing company that’s focused on healthcare, has added $8 million to its Series B round, care of Kaiser Permanente Ventures and CHV Capital. Previously, the company had raised $33 million for its Series B, from investors that include Norwest Venture Partners, Sequoia Capital and Sorenson Capital.

Continue

Valeritas Lands $150M Series C

4 years ago

Valeritas Inc., a Bridgewater, N.J.-based developer of drug delivery systems for the diabetes market, has raised $150 million in Series C financing. The funding will support commercialization of its V-Go disposable insulin delivery device. Welsh, Carson, Anderson & Stowe led the financing and assumes a controlling interest in Valeritas. Previous investors MPM Capital, Pitango Venture Capital, Abingworth Management, Advanced Technology Ventures, ONSET Ventures, HLM Venture Partners, Agate Medical Investments, CHL Medical Partners and Kaiser Permanente Ventures also participated.

Continue

Kaiser Permanente Ventures Adds LPs, Expands Team

5 years ago

Kaiser Permanente Ventures has added two new limited partners, bringing its current fund to $170 million, the firm announced. It has also expanded its team, adding Sam Brasch as a director and Yan Pu as an analyst. Brasch was most recently at Frazier Healthcare Ventures. Pu worked previously in life sciences and healthcare strategy consulting with IMS Health and Navigant Consulting. Kaiser Permanente Ventures invests in medical device, health care service, diagnostic and drug delivery.

Continue

Transcend Medical Sews Up $51M Series B

5 years ago

Transcend Medical Inc., a Menlo Park, Calif.-based ophthalmic device company, has closed a second tranche of its Series B round, bringing the total to an eye-popping $51 million. Investors include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners. The company says it will use the funds to develop additional infrastructure and resources for a U.S. study of its micro-stent technology. The company is focused on minimally invasive glaucoma therapies.

Continue

Will the Frosty Reception for AcelRX Put Other IPOs on Ice?

By Connie Loizos — 5 years ago

Life can be hard for young biotechs, but that doesn’t mean the market is sympathetic.  AcelRX Pharmaceuticals of Redwood City, Calif., is the latest biotech to receive a cold reception from investors. After slashing its planned offering price from between $12 and $14 to $5 per share, the stock has been trending downward since its debut […]

Continue